Hot Investor Mandate: USA Family Office Invests Up to $10M in Life Science & Healthcare Companies that Target Oncology & Ophthalmology

6 Feb

A family investment group based in the USA is looking to invest in technologies related to ophthalmology and oncology that are in the pre-clinical to Ph I stages. The firm will invest in seed and series A rounds up to $10M. The firm is willing to invest globally, with a special interest in companies based in North America, Europe and China.

The firm is interested in therapeutics, medical device and diagnostics companies with technologies in the ophthalmology and oncology spaces. The firm may consider digital health companies as well. For ophthalmology-related companies, Halcyon is most interested in small molecules or combination devices. For oncology-related companies, the firm prefers I/O technologies or diagnostics.

The firm prefers to take a board seat after investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: